glp 1 injections hims Tumbles 19% After CEO Says It's Phasing Out Weight Loss Copies Hims' Pivot to Branded Obesity

Browse all Peptides & GLP-1 education Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings | Reviewed by: Jayden Lee, PharmD This is an independent editorial review

It is a critical component of metabolic health and healthy ageing

doi: 10.1016/S0167-0115(97)00009-8 63 HinkeSAManhartSPamirNDemuthHUGellingRWPedersonRAet al

Semaglutide, originally developed for diabetes management, showed significant weight loss results in both clinical trials and real-world settings, which attracted widespread adoption

K.YangL

Mounjaro for type 2 diabetes typically has broader coverage through commercial plans, Medicare Part D, and Medicaid with prior authorization